ClinicalTrials.govpublic full text
Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM
nash - nonalcoholic steatohepatitis, nafld, t2dm (type 2 diabetes mellitus)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 651202
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.